Skip to content

D47.Z1

Billable

Post-transplant lymphoproliferative disorder (PTLD)

HCC Category Mapping

V28HCC 21Breast, Prostate, Colorectal and Other Cancers and Tumors
0.545
V24HCC 48Coagulation Defects and Other Specified Hematological Disorders
0.209
ESRDHCC 48Coagulation Defects and Other Specified Hematological Disorders
0.000

What This Code Means

An abnormal growth of lymphoid cells that develops after an organ or tissue transplant due to weakened immune function.

Coding Tips

  • Always link this diagnosis to a transplant procedure; document the type of transplant (bone marrow, solid organ, etc.)
  • Include the timeframe of PTLD development relative to transplant date in clinical documentation

Clinical Significance

Post-transplant lymphoproliferative disorder is a potentially life-threatening complication of solid organ or hematopoietic stem cell transplantation, resulting from uncontrolled lymphoid proliferation due to immunosuppression. The spectrum ranges from benign polyclonal hyperplasia to aggressive monoclonal lymphoma, and it is frequently associated with Epstein-Barr virus reactivation in the immunosuppressed host.

Documentation Requirements

  • Documentation must link the lymphoproliferative disorder to a prior transplant, specifying the type of transplant (kidney, liver, heart, lung, bone marrow) and timing of onset relative to transplantation.
  • Tissue biopsy confirming lymphoid proliferation is required.
  • Epstein-Barr virus status (viral load, in situ hybridization), immunosuppression regimen, and pathologic subtype (early lesion, polymorphic, monomorphic) should be documented.

Code First

  • complications of transplanted organs and tissue (T86.-)

Commonly Confused Codes

Code Hierarchy

Open D47.Z1 in the Interactive Encoder

See full code details, AI coding tips, HCC mappings, and related codes in our interactive encoder. Start your 14-day Pro trial — no credit card required.